NCT04002154 - Clinical Trial to Explore the Papilocare Gel Efficacy to Repair the Cervico-vaginal Mucosa With Lesions Caused by HPV | Biotech Hunter

Enrollment

134

Participants

Timeline

Start Date

October 19, 2015

Primary Completion Date

July 31, 2018

Study Completion Date

February 28, 2019

Conditions

Human Papilloma Virus InfectionHuman Papilloma VirusCervix Lesion

Interventions

DEVICE

Papilocare vaginal gel

Papilocare is a gel vaginally administered by a single-dose cannula. Vaginal gel formulation is effective as a local treatment with controlled systemic absorption and rapid and efficient distribution

Trial Locations (9)

28001

Gabinete Médico Velázquez, Madrid

28031

Hospital Infanta Leonor, Madrid

28040

Hospital Clínico San Carlos, Madrid

29004

Hospital Quirón Málaga, Málaga

41720

Instituto Palacios de Salud y Medicina de la Mujer, Madrid

03010

Hospital General Universitario de Alicante, Alicante

08017

Clínica Diatros - TEKNON, Barcelona

Women´s Health Institute, Barcelona

08041

Hospital de la Santa Creu i Sant Pau, Barcelona